PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.94%
Net income growth under 50% of BB's 24.27%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
15.72%
D&A growth well above BB's 0.97%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-25.15%
Negative yoy deferred tax while BB stands at 100.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
5.04%
Less SBC growth vs. BB's 60.00%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-88.08%
Negative yoy working capital usage while BB is 162.44%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
205.97%
AR growth well above BB's 287.11%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-778.18%
Both reduce yoy inventory, with BB at -100.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-121.79%
Both negative yoy AP, with BB at -195956.34%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-173.54%
Both reduce yoy usage, with BB at -320.38%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-100.51%
Both negative yoy, with BB at -109.57%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-8.11%
Both yoy CFO lines are negative, with BB at -0.51%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-7.57%
Negative yoy CapEx while BB is 49.54%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-37.78%
Negative yoy acquisition while BB stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
42.78%
Purchases well above BB's 20.42%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
14.64%
Below 50% of BB's 14072.64%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-139.01%
Both yoy lines negative, with BB at -2499999900.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-2.38%
We reduce yoy invests while BB stands at 60.43%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
52.09%
Debt repayment at 50-75% of BB's 100.00%. Martin Whitman would worry about partial lag if competitor gains advantage from lower debt burdens.
32.21%
We slightly raise equity while BB is negative at -50.00%. John Neff sees competitor possibly preserving share count or buying back shares.
2.45%
Buyback growth of 2.45% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.